You are here

Sistemik lupus eritematozus tartılı bir olguda akciğer, plevra ve bağırsak tüberkülozu: olgu sunumu

Pulmonary, pleural and intestinal tuberculosis in a case with the diagnosis of systemic lupus erythematosus: a case report

Journal Name:

Publication Year:

Abstract (2. Language): 
Systemic lupus erythematosus (SLE) is an aotuimmune disease that characterized multisystem involvement. Recently, there are many reports about an increased risk for opportunistic infections, especially pulmonary and extrapulmonary tuberculosis in patients with SLE. A 35-year old female patient, who had been followed with the diagnosis of SLE, diffuse glomerulonephritis and hypertension for six years, admitted to our clinic with the complaints of chill, fever, fatigue and weight loss. The chest roentgenogram showed an increased homogenous density in the left middle and the basal lung zones. It was learned that the patient was undergone the operation of hemicolectomi with the diagnosis of acute abdomen one month ago. The pathological examination of the specimen was showed a granulomatous inflammation with caseification necrosis. Any granuloma was seen on the bronchoscopic biopsies. The direct examination and culture of the bronchial lavage for acid -fast bacilli was negative. The level of adenosine deaminase in pleural fluid was 182 U/L. With the laboratory and clinical findings, activation of lupus was excluded and the low dose cortisone therapy was continued. The antituberculosis treatment was given with the diagnosis of bowel tuberculosis, sputum smear negative pulmonary tuberculosis and tuberculous pleurisy. By the clinical and radiological improvement, the treatment was completed in 9 months.
Abstract (Original Language): 
Sistemik Lupus Eritematozus (SLE), birçok organ sistemlerinin tutulumu ile karakterize otoimmün bir hastalıktır. Son zamanlarda, SLE hastalarında fırsatçı enfeksiyon riskinde, özellikle de akciğer tüberkülozu ve akciğer dışı organ tüberkülozunda artma olduğuna dair bir çok yayın bulunmaktadır. Altı yıldır SLE, diffüz proliferatif glomerülonefrit (DPGN) ve hipertansiyon tanıları ile takip edilen 35 yaşında bayan hasta üşüme, titreme, ateş, halsizlik ve kilo kaybı yakınmaları ile kliniğimize başvurdu. Akciğer grafisinde, sol akciğer orta ve alt zonda efüzyon ile uyumlu açıklığı yukarı bakan homojen dansite artışı izlendi. Hastanın öyküsünden 1 ay önce akut batın ön tanısıyla sağ hemikolektomi operasyonu geçirdiği öğrenildi. Ameliyat materyalinin patoloji sonucu kazeifikasyon nekrozu içeren granülomatöz inflamasyon ile uyumlu idi. Bronkoskopik biyopsilerde granülom görülmedi. Bronş lavajının direkt bakısında asido rezistan bakteri (ARB) negatifti ve aynı materyalin kültüründe ARB üremedi. Plevral sıvıda adenozin deaminaz düzeyi (ADA) 182U/L idi. Klinik ve laboratuar bulguları ile lupus aktivasyonu dışlanan olguda kullanmakta olduğu düşük doz kortizon tedavisine devam edildi. Bağırsak tüberkülozu, yayma negatif akciğer tüberkülozu ve tüberküloz plörezi tanıları ile antitüberküloz tedavi başlandı. Antitüberküloz tedavi ile klinik ve radyolojik düzelme görülen olguda tedavi 9 aya tamamlandı.
34-38

REFERENCES

References: 

1- Arnow PM, Flaherty JP. Fever ofunknown origin. Lancet 1997; 350: 575-580
2- Zumla A, James DG. Granulomatous infections: etiology and classification. Clin Infect Dis 1996; 23: 146-158
3- Fraser RS, Müler NL, Colman N, Pare PD. Connective tissue diseases. In: Diagnosis ofDisease ofThe Chest. 4th ed. Philedelphia: WB SaunderCo,1999; 1421-88
4- Dubois EL, Tuffanelli DL. Clinical manifestations of
systemic lupus erythematosus: computer analysis of520 cases. JAMA 1964; 190: 104-111
5- Francisco P, Quismorio Jr. Pulmonary manifestations ofsystemic lupus erythematosus. In Wallace DJ, Hahn BD, eds. Dubois lupus erythematosus. 5th.ed. Baltimore: Williams andwilkins Comp, 1997: 673¬692
6- Good JT Jr, King TE, Antony VB, Sahn SA. Lupus Pleuritis: Clinical Factors and pleural Fluid Characteristics with special reference to pleural fluid antinuclearantibodies. Chest 1983; 84: 714-718
7- Michael PA, Lynch JP. Pleuropulmonary manifestations ofsystemic lupus erythematosus. Thorax 2000; 35:
159-166
8- Paton NI. Infections in systemic lupus erythematosus patients. AnnAcad Med Singapore 1997; 26: 694-700
9- Sayarlıoğlu M, Inanç M, Kamali S, Cefle A, Karaman O, Gul A, et al. Tuberculosis in Turkish Patients with Systemic Lupus Erythematosus: Increased Frequency ofExtrapulmonaryLocalization. Lupus 2004;13: 274¬278
10- Ginzler E, Diamond H, Kaplan D, Weiner M,, . Computer analysis offactors influencing frequency of infection in systemic lupus erythematosus. Arthritis andRheum 1978; 21: 37-44
11- Noel V, Lortholary O, Casassus P, Cohen P, Genereau T, Andre MH, et al. Risk factors and prognostic influence ofinfection in a single cohort of87 adults with systemic lupus erythematosus. Ann Rheum Dis 2001; 60: 1141-1144.
12- Yu CL, Chang KL, Chiu CC, Chiang BN, Han SH, Wang SR. Defective phagocytosis, decreased tumour necrosis factor-alpha production, and lymphocyte hyperresponsiveness predispose patients with systemic lupus erythematosus to infections. Scand J Rheumatol 1989; 18: 97-105.
13- Hernandez-Cruz B, Sifuentes-Osornio J, Ponce-de-Leon Rosales S, Ponce-de-Leon Garduno A, Diaz-Jouanen E. Mycobacterium tuberculosis infection in patients with systemic rheumatic diseases. A case series. ClinExp Rheumatol 1999; 17: 289-296.

Thank you for copying data from http://www.arastirmax.com